Captozyme Initiates Clinical Study of Nephure™ Oxalate-Reducing Enzyme (BusinessWire)
UF Innovate incubator graduate Captozyme, Inc. announced that it is initiating a prospective double-blind, randomized, placebo controlled, cross-over study, with Nephure™, an oxalate reducing enzyme,... Read More